nodes	percent_of_prediction	percent_of_DWPC	metapath
Ivacaftor—ORM1—Erlotinib—pancreatic cancer	0.176	0.243	CbGbCtD
Ivacaftor—CFTR—ventral pancreatic duct—pancreatic cancer	0.0759	0.552	CbGeAlD
Ivacaftor—ALB—Erlotinib—pancreatic cancer	0.074	0.102	CbGbCtD
Ivacaftor—ALB—Irinotecan—pancreatic cancer	0.0668	0.0924	CbGbCtD
Ivacaftor—ALB—Fluorouracil—pancreatic cancer	0.0641	0.0887	CbGbCtD
Ivacaftor—ABCB1—Tamoxifen—pancreatic cancer	0.0455	0.063	CbGbCtD
Ivacaftor—ABCB1—Gemcitabine—pancreatic cancer	0.0392	0.0542	CbGbCtD
Ivacaftor—ABCB1—Erlotinib—pancreatic cancer	0.0387	0.0535	CbGbCtD
Ivacaftor—ABCB1—Irinotecan—pancreatic cancer	0.035	0.0484	CbGbCtD
Ivacaftor—CYP3A4—Tamoxifen—pancreatic cancer	0.0273	0.0377	CbGbCtD
Ivacaftor—ABCB1—Docetaxel—pancreatic cancer	0.0256	0.0354	CbGbCtD
Ivacaftor—ABCB1—Sunitinib—pancreatic cancer	0.0255	0.0353	CbGbCtD
Ivacaftor—CYP3A4—Erlotinib—pancreatic cancer	0.0232	0.0321	CbGbCtD
Ivacaftor—CYP3A4—Irinotecan—pancreatic cancer	0.0209	0.029	CbGbCtD
Ivacaftor—ORM1—bile—pancreatic cancer	0.0202	0.146	CbGeAlD
Ivacaftor—ABCB1—Doxorubicin—pancreatic cancer	0.0191	0.0264	CbGbCtD
Ivacaftor—CYP3A4—Docetaxel—pancreatic cancer	0.0154	0.0212	CbGbCtD
Ivacaftor—CYP3A4—Sunitinib—pancreatic cancer	0.0153	0.0211	CbGbCtD
Ivacaftor—CYP3A4—Doxorubicin—pancreatic cancer	0.0114	0.0158	CbGbCtD
Ivacaftor—CFTR—gall bladder—pancreatic cancer	0.011	0.08	CbGeAlD
Ivacaftor—Bilirubin total increased—Sunitinib—pancreatic cancer	0.00878	0.0631	CcSEcCtD
Ivacaftor—CFTR—islet of Langerhans—pancreatic cancer	0.00722	0.0525	CbGeAlD
Ivacaftor—ORM1—gall bladder—pancreatic cancer	0.00559	0.0406	CbGeAlD
Ivacaftor—CFTR—pancreas—pancreatic cancer	0.00508	0.0369	CbGeAlD
Ivacaftor—ALB—gall bladder—pancreatic cancer	0.00491	0.0356	CbGeAlD
Ivacaftor—CFTR—digestive system—pancreatic cancer	0.00434	0.0315	CbGeAlD
Ivacaftor—Blood glucose increased—Sunitinib—pancreatic cancer	0.00344	0.0247	CcSEcCtD
Ivacaftor—Bilirubin total increased—Epirubicin—pancreatic cancer	0.00337	0.0242	CcSEcCtD
Ivacaftor—Bilirubin total increased—Doxorubicin—pancreatic cancer	0.00312	0.0224	CcSEcCtD
Ivacaftor—Mastitis—Epirubicin—pancreatic cancer	0.00277	0.0199	CcSEcCtD
Ivacaftor—Mastitis—Doxorubicin—pancreatic cancer	0.00257	0.0184	CcSEcCtD
Ivacaftor—Transaminases increased—Gemcitabine—pancreatic cancer	0.00233	0.0167	CcSEcCtD
Ivacaftor—Hyperaesthesia—Sunitinib—pancreatic cancer	0.00225	0.0161	CcSEcCtD
Ivacaftor—Blood bilirubin increased—Tamoxifen—pancreatic cancer	0.00218	0.0156	CcSEcCtD
Ivacaftor—Oropharyngeal pain—Sunitinib—pancreatic cancer	0.00194	0.0139	CcSEcCtD
Ivacaftor—Blood bilirubin increased—Sunitinib—pancreatic cancer	0.00186	0.0134	CcSEcCtD
Ivacaftor—Musculoskeletal chest pain—Epirubicin—pancreatic cancer	0.00175	0.0125	CcSEcCtD
Ivacaftor—Musculoskeletal chest pain—Doxorubicin—pancreatic cancer	0.00162	0.0116	CcSEcCtD
Ivacaftor—Blood bilirubin increased—Irinotecan—pancreatic cancer	0.00154	0.011	CcSEcCtD
Ivacaftor—Hepatic enzyme increased—Gemcitabine—pancreatic cancer	0.0015	0.0107	CcSEcCtD
Ivacaftor—Blood bilirubin increased—Gemcitabine—pancreatic cancer	0.0015	0.0107	CcSEcCtD
Ivacaftor—Nasal congestion—Sunitinib—pancreatic cancer	0.0014	0.0101	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Tamoxifen—pancreatic cancer	0.00135	0.00966	CcSEcCtD
Ivacaftor—Hypoglycaemia—Sunitinib—pancreatic cancer	0.00131	0.00941	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Sunitinib—pancreatic cancer	0.00115	0.00827	CcSEcCtD
Ivacaftor—Nasopharyngitis—Sunitinib—pancreatic cancer	0.00114	0.00821	CcSEcCtD
Ivacaftor—Infestation NOS—Erlotinib—pancreatic cancer	0.00114	0.00818	CcSEcCtD
Ivacaftor—Infestation—Erlotinib—pancreatic cancer	0.00114	0.00818	CcSEcCtD
Ivacaftor—Transaminases increased—Epirubicin—pancreatic cancer	0.00111	0.00799	CcSEcCtD
Ivacaftor—Oropharyngeal pain—Docetaxel—pancreatic cancer	0.0011	0.00792	CcSEcCtD
Ivacaftor—ABCB1—islet of Langerhans—pancreatic cancer	0.00108	0.00787	CbGeAlD
Ivacaftor—Blood bilirubin increased—Docetaxel—pancreatic cancer	0.00106	0.00762	CcSEcCtD
Ivacaftor—Transaminases increased—Doxorubicin—pancreatic cancer	0.00103	0.00739	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Sunitinib—pancreatic cancer	0.00103	0.00738	CcSEcCtD
Ivacaftor—Connective tissue disorder—Erlotinib—pancreatic cancer	0.001	0.00721	CcSEcCtD
Ivacaftor—Infestation NOS—Sunitinib—pancreatic cancer	0.000986	0.00708	CcSEcCtD
Ivacaftor—Infestation—Sunitinib—pancreatic cancer	0.000986	0.00708	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Irinotecan—pancreatic cancer	0.000949	0.00681	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Gemcitabine—pancreatic cancer	0.000925	0.00664	CcSEcCtD
Ivacaftor—Mediastinal disorder—Erlotinib—pancreatic cancer	0.000922	0.00662	CcSEcCtD
Ivacaftor—CYP3A4—digestive system—pancreatic cancer	0.000919	0.00668	CbGeAlD
Ivacaftor—Nasopharyngitis—Fluorouracil—pancreatic cancer	0.000903	0.00648	CcSEcCtD
Ivacaftor—Connective tissue disorder—Sunitinib—pancreatic cancer	0.00087	0.00625	CcSEcCtD
Ivacaftor—Hyperaesthesia—Epirubicin—pancreatic cancer	0.000863	0.00619	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Irinotecan—pancreatic cancer	0.000847	0.00608	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Fluorouracil—pancreatic cancer	0.000811	0.00582	CcSEcCtD
Ivacaftor—Hyperaesthesia—Doxorubicin—pancreatic cancer	0.000798	0.00573	CcSEcCtD
Ivacaftor—Mediastinal disorder—Sunitinib—pancreatic cancer	0.000798	0.00573	CcSEcCtD
Ivacaftor—Infestation NOS—Fluorouracil—pancreatic cancer	0.000778	0.00558	CcSEcCtD
Ivacaftor—Infestation—Fluorouracil—pancreatic cancer	0.000778	0.00558	CcSEcCtD
Ivacaftor—Myalgia—Tamoxifen—pancreatic cancer	0.000766	0.0055	CcSEcCtD
Ivacaftor—Arthralgia—Tamoxifen—pancreatic cancer	0.000766	0.0055	CcSEcCtD
Ivacaftor—ABCB1—pancreas—pancreatic cancer	0.000762	0.00553	CbGeAlD
Ivacaftor—Arthralgia—Erlotinib—pancreatic cancer	0.000758	0.00544	CcSEcCtD
Ivacaftor—Myalgia—Erlotinib—pancreatic cancer	0.000758	0.00544	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.000753	0.0054	CcSEcCtD
Ivacaftor—Rhinitis—Irinotecan—pancreatic cancer	0.000731	0.00525	CcSEcCtD
Ivacaftor—Infection—Tamoxifen—pancreatic cancer	0.00073	0.00524	CcSEcCtD
Ivacaftor—Infection—Erlotinib—pancreatic cancer	0.000722	0.00518	CcSEcCtD
Ivacaftor—Connective tissue disorder—Irinotecan—pancreatic cancer	0.000717	0.00514	CcSEcCtD
Ivacaftor—Blood bilirubin increased—Epirubicin—pancreatic cancer	0.000716	0.00514	CcSEcCtD
Ivacaftor—Nervous system disorder—Erlotinib—pancreatic cancer	0.000713	0.00511	CcSEcCtD
Ivacaftor—Rhinitis—Gemcitabine—pancreatic cancer	0.000712	0.00511	CcSEcCtD
Ivacaftor—Skin disorder—Erlotinib—pancreatic cancer	0.000706	0.00507	CcSEcCtD
Ivacaftor—Rhinitis—Fluorouracil—pancreatic cancer	0.0007	0.00503	CcSEcCtD
Ivacaftor—Connective tissue disorder—Gemcitabine—pancreatic cancer	0.000698	0.00501	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.000669	0.0048	CcSEcCtD
Ivacaftor—Blood bilirubin increased—Doxorubicin—pancreatic cancer	0.000662	0.00475	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.000662	0.00475	CcSEcCtD
Ivacaftor—Breast disorder—Docetaxel—pancreatic cancer	0.000658	0.00473	CcSEcCtD
Ivacaftor—Mediastinal disorder—Irinotecan—pancreatic cancer	0.000657	0.00472	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Docetaxel—pancreatic cancer	0.000656	0.00471	CcSEcCtD
Ivacaftor—Myalgia—Sunitinib—pancreatic cancer	0.000656	0.00471	CcSEcCtD
Ivacaftor—Arthralgia—Sunitinib—pancreatic cancer	0.000656	0.00471	CcSEcCtD
Ivacaftor—Nasopharyngitis—Docetaxel—pancreatic cancer	0.000652	0.00468	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000652	0.00468	CcSEcCtD
Ivacaftor—ABCB1—digestive system—pancreatic cancer	0.000651	0.00473	CbGeAlD
Ivacaftor—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.00064	0.0046	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000634	0.00455	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000627	0.0045	CcSEcCtD
Ivacaftor—Infection—Sunitinib—pancreatic cancer	0.000625	0.00449	CcSEcCtD
Ivacaftor—Nervous system disorder—Sunitinib—pancreatic cancer	0.000617	0.00443	CcSEcCtD
Ivacaftor—Skin disorder—Sunitinib—pancreatic cancer	0.000611	0.00439	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.0006	0.00431	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000594	0.00426	CcSEcCtD
Ivacaftor—Abdominal pain—Tamoxifen—pancreatic cancer	0.000581	0.00417	CcSEcCtD
Ivacaftor—Abdominal pain—Erlotinib—pancreatic cancer	0.000574	0.00412	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000573	0.00411	CcSEcCtD
Ivacaftor—Infestation—Docetaxel—pancreatic cancer	0.000562	0.00403	CcSEcCtD
Ivacaftor—Infestation NOS—Docetaxel—pancreatic cancer	0.000562	0.00403	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000543	0.0039	CcSEcCtD
Ivacaftor—Arthralgia—Gemcitabine—pancreatic cancer	0.000526	0.00378	CcSEcCtD
Ivacaftor—Myalgia—Gemcitabine—pancreatic cancer	0.000526	0.00378	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000523	0.00375	CcSEcCtD
Ivacaftor—Myalgia—Fluorouracil—pancreatic cancer	0.000518	0.00372	CcSEcCtD
Ivacaftor—Infection—Irinotecan—pancreatic cancer	0.000515	0.00369	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000514	0.00369	CcSEcCtD
Ivacaftor—Nervous system disorder—Irinotecan—pancreatic cancer	0.000508	0.00365	CcSEcCtD
Ivacaftor—Rhinitis—Docetaxel—pancreatic cancer	0.000505	0.00363	CcSEcCtD
Ivacaftor—Hypoglycaemia—Epirubicin—pancreatic cancer	0.000504	0.00362	CcSEcCtD
Ivacaftor—Diarrhoea—Tamoxifen—pancreatic cancer	0.000502	0.00361	CcSEcCtD
Ivacaftor—Infection—Gemcitabine—pancreatic cancer	0.000501	0.0036	CcSEcCtD
Ivacaftor—Abdominal pain—Sunitinib—pancreatic cancer	0.000497	0.00357	CcSEcCtD
Ivacaftor—Diarrhoea—Erlotinib—pancreatic cancer	0.000497	0.00357	CcSEcCtD
Ivacaftor—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000495	0.00356	CcSEcCtD
Ivacaftor—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000495	0.00355	CcSEcCtD
Ivacaftor—Infection—Fluorouracil—pancreatic cancer	0.000493	0.00354	CcSEcCtD
Ivacaftor—Skin disorder—Gemcitabine—pancreatic cancer	0.00049	0.00352	CcSEcCtD
Ivacaftor—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000487	0.00349	CcSEcCtD
Ivacaftor—Dizziness—Tamoxifen—pancreatic cancer	0.000486	0.00349	CcSEcCtD
Ivacaftor—Dizziness—Erlotinib—pancreatic cancer	0.00048	0.00345	CcSEcCtD
Ivacaftor—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.000466	0.00335	CcSEcCtD
Ivacaftor—Rash—Tamoxifen—pancreatic cancer	0.000463	0.00332	CcSEcCtD
Ivacaftor—Dermatitis—Tamoxifen—pancreatic cancer	0.000463	0.00332	CcSEcCtD
Ivacaftor—Headache—Tamoxifen—pancreatic cancer	0.00046	0.0033	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00046	0.0033	CcSEcCtD
Ivacaftor—Rash—Erlotinib—pancreatic cancer	0.000458	0.00329	CcSEcCtD
Ivacaftor—Dermatitis—Erlotinib—pancreatic cancer	0.000458	0.00329	CcSEcCtD
Ivacaftor—Headache—Erlotinib—pancreatic cancer	0.000455	0.00327	CcSEcCtD
Ivacaftor—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000454	0.00326	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000452	0.00325	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000447	0.00321	CcSEcCtD
Ivacaftor—Breast disorder—Epirubicin—pancreatic cancer	0.000444	0.00319	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000443	0.00318	CcSEcCtD
Ivacaftor—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000439	0.00315	CcSEcCtD
Ivacaftor—Nausea—Tamoxifen—pancreatic cancer	0.000436	0.00313	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000436	0.00313	CcSEcCtD
Ivacaftor—Nausea—Erlotinib—pancreatic cancer	0.000432	0.0031	CcSEcCtD
Ivacaftor—Diarrhoea—Sunitinib—pancreatic cancer	0.00043	0.00309	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000428	0.00308	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000424	0.00304	CcSEcCtD
Ivacaftor—Dizziness—Sunitinib—pancreatic cancer	0.000416	0.00299	CcSEcCtD
Ivacaftor—Breast disorder—Doxorubicin—pancreatic cancer	0.000411	0.00295	CcSEcCtD
Ivacaftor—Abdominal pain—Irinotecan—pancreatic cancer	0.00041	0.00294	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.00041	0.00294	CcSEcCtD
Ivacaftor—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000407	0.00292	CcSEcCtD
Ivacaftor—Rash—Sunitinib—pancreatic cancer	0.000397	0.00285	CcSEcCtD
Ivacaftor—Dermatitis—Sunitinib—pancreatic cancer	0.000396	0.00284	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000395	0.00283	CcSEcCtD
Ivacaftor—Headache—Sunitinib—pancreatic cancer	0.000394	0.00283	CcSEcCtD
Ivacaftor—Infestation NOS—Epirubicin—pancreatic cancer	0.000379	0.00272	CcSEcCtD
Ivacaftor—Infestation—Epirubicin—pancreatic cancer	0.000379	0.00272	CcSEcCtD
Ivacaftor—Arthralgia—Docetaxel—pancreatic cancer	0.000374	0.00268	CcSEcCtD
Ivacaftor—Myalgia—Docetaxel—pancreatic cancer	0.000374	0.00268	CcSEcCtD
Ivacaftor—Nausea—Sunitinib—pancreatic cancer	0.000374	0.00268	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000371	0.00266	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000365	0.00262	CcSEcCtD
Ivacaftor—Infection—Docetaxel—pancreatic cancer	0.000356	0.00255	CcSEcCtD
Ivacaftor—Diarrhoea—Irinotecan—pancreatic cancer	0.000354	0.00254	CcSEcCtD
Ivacaftor—Nervous system disorder—Docetaxel—pancreatic cancer	0.000351	0.00252	CcSEcCtD
Ivacaftor—Infestation—Doxorubicin—pancreatic cancer	0.00035	0.00252	CcSEcCtD
Ivacaftor—Infestation NOS—Doxorubicin—pancreatic cancer	0.00035	0.00252	CcSEcCtD
Ivacaftor—Skin disorder—Docetaxel—pancreatic cancer	0.000348	0.0025	CcSEcCtD
Ivacaftor—Diarrhoea—Gemcitabine—pancreatic cancer	0.000345	0.00248	CcSEcCtD
Ivacaftor—Dizziness—Irinotecan—pancreatic cancer	0.000343	0.00246	CcSEcCtD
Ivacaftor—Rhinitis—Epirubicin—pancreatic cancer	0.000341	0.00245	CcSEcCtD
Ivacaftor—Diarrhoea—Fluorouracil—pancreatic cancer	0.00034	0.00244	CcSEcCtD
Ivacaftor—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000334	0.0024	CcSEcCtD
Ivacaftor—Dizziness—Fluorouracil—pancreatic cancer	0.000328	0.00236	CcSEcCtD
Ivacaftor—Rash—Irinotecan—pancreatic cancer	0.000327	0.00234	CcSEcCtD
Ivacaftor—Dermatitis—Irinotecan—pancreatic cancer	0.000326	0.00234	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000326	0.00234	CcSEcCtD
Ivacaftor—Headache—Irinotecan—pancreatic cancer	0.000325	0.00233	CcSEcCtD
Ivacaftor—Rash—Gemcitabine—pancreatic cancer	0.000318	0.00228	CcSEcCtD
Ivacaftor—Dermatitis—Gemcitabine—pancreatic cancer	0.000318	0.00228	CcSEcCtD
Ivacaftor—Tinnitus—Epirubicin—pancreatic cancer	0.000317	0.00228	CcSEcCtD
Ivacaftor—Headache—Gemcitabine—pancreatic cancer	0.000316	0.00227	CcSEcCtD
Ivacaftor—Rhinitis—Doxorubicin—pancreatic cancer	0.000315	0.00226	CcSEcCtD
Ivacaftor—Rash—Fluorouracil—pancreatic cancer	0.000313	0.00225	CcSEcCtD
Ivacaftor—Dermatitis—Fluorouracil—pancreatic cancer	0.000313	0.00224	CcSEcCtD
Ivacaftor—Headache—Fluorouracil—pancreatic cancer	0.000311	0.00223	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000309	0.00222	CcSEcCtD
Ivacaftor—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000309	0.00222	CcSEcCtD
Ivacaftor—Nausea—Irinotecan—pancreatic cancer	0.000308	0.00221	CcSEcCtD
Ivacaftor—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000306	0.0022	CcSEcCtD
Ivacaftor—Nausea—Gemcitabine—pancreatic cancer	0.0003	0.00215	CcSEcCtD
Ivacaftor—Nausea—Fluorouracil—pancreatic cancer	0.000295	0.00212	CcSEcCtD
Ivacaftor—Tinnitus—Doxorubicin—pancreatic cancer	0.000293	0.00211	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000293	0.0021	CcSEcCtD
Ivacaftor—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000284	0.00204	CcSEcCtD
Ivacaftor—Abdominal pain—Docetaxel—pancreatic cancer	0.000283	0.00203	CcSEcCtD
Ivacaftor—Arthralgia—Epirubicin—pancreatic cancer	0.000252	0.00181	CcSEcCtD
Ivacaftor—Myalgia—Epirubicin—pancreatic cancer	0.000252	0.00181	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.00025	0.0018	CcSEcCtD
Ivacaftor—Diarrhoea—Docetaxel—pancreatic cancer	0.000245	0.00176	CcSEcCtD
Ivacaftor—Infection—Epirubicin—pancreatic cancer	0.00024	0.00172	CcSEcCtD
Ivacaftor—Nervous system disorder—Epirubicin—pancreatic cancer	0.000237	0.0017	CcSEcCtD
Ivacaftor—Dizziness—Docetaxel—pancreatic cancer	0.000237	0.0017	CcSEcCtD
Ivacaftor—Skin disorder—Epirubicin—pancreatic cancer	0.000235	0.00168	CcSEcCtD
Ivacaftor—Arthralgia—Doxorubicin—pancreatic cancer	0.000233	0.00167	CcSEcCtD
Ivacaftor—Myalgia—Doxorubicin—pancreatic cancer	0.000233	0.00167	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000232	0.00166	CcSEcCtD
Ivacaftor—Rash—Docetaxel—pancreatic cancer	0.000226	0.00162	CcSEcCtD
Ivacaftor—Dermatitis—Docetaxel—pancreatic cancer	0.000226	0.00162	CcSEcCtD
Ivacaftor—Headache—Docetaxel—pancreatic cancer	0.000224	0.00161	CcSEcCtD
Ivacaftor—Infection—Doxorubicin—pancreatic cancer	0.000222	0.00159	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.00022	0.00158	CcSEcCtD
Ivacaftor—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000219	0.00157	CcSEcCtD
Ivacaftor—Skin disorder—Doxorubicin—pancreatic cancer	0.000217	0.00156	CcSEcCtD
Ivacaftor—Nausea—Docetaxel—pancreatic cancer	0.000213	0.00153	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000209	0.0015	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000204	0.00146	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000198	0.00142	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000193	0.00139	CcSEcCtD
Ivacaftor—Abdominal pain—Epirubicin—pancreatic cancer	0.000191	0.00137	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000183	0.00131	CcSEcCtD
Ivacaftor—Abdominal pain—Doxorubicin—pancreatic cancer	0.000177	0.00127	CcSEcCtD
Ivacaftor—Diarrhoea—Epirubicin—pancreatic cancer	0.000165	0.00119	CcSEcCtD
Ivacaftor—Dizziness—Epirubicin—pancreatic cancer	0.00016	0.00115	CcSEcCtD
Ivacaftor—Diarrhoea—Doxorubicin—pancreatic cancer	0.000153	0.0011	CcSEcCtD
Ivacaftor—Rash—Epirubicin—pancreatic cancer	0.000152	0.00109	CcSEcCtD
Ivacaftor—Dermatitis—Epirubicin—pancreatic cancer	0.000152	0.00109	CcSEcCtD
Ivacaftor—Headache—Epirubicin—pancreatic cancer	0.000151	0.00109	CcSEcCtD
Ivacaftor—Dizziness—Doxorubicin—pancreatic cancer	0.000148	0.00106	CcSEcCtD
Ivacaftor—Nausea—Epirubicin—pancreatic cancer	0.000143	0.00103	CcSEcCtD
Ivacaftor—Rash—Doxorubicin—pancreatic cancer	0.000141	0.00101	CcSEcCtD
Ivacaftor—Dermatitis—Doxorubicin—pancreatic cancer	0.000141	0.00101	CcSEcCtD
Ivacaftor—Headache—Doxorubicin—pancreatic cancer	0.00014	0.00101	CcSEcCtD
Ivacaftor—Nausea—Doxorubicin—pancreatic cancer	0.000133	0.000953	CcSEcCtD
